S. Kırlı

发表

Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems

A. Sarandol, E. Sarandol, S. Eker, 2007, Human psychopharmacology.

The potential relationship between QTc interval prolongation and ziprasidone treatment: three cases

A. Sarandol, S. Eker, S. Kırlı, 2009, Journal of psychopharmacology.

Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment

A. Sarandol, E. Sarandol, S. Kırlı, 2007, Journal of psychopharmacology.

Prediction of Depression in Schizophrenia: Can serum Levels of BDNF or EGFHelp us?

E. Sarandol, S. Eker, S. Kırlı, 2014 .

Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder

A. Sarandol, E. Sarandol, S. Eker, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study

S. Eker, S. Kırlı, C. Akkaya, 2006, Human psychopharmacology.

Effects of various antidepressants on serum thyroid hormone levels in patients with major depressive disorder

A. Sarandol, E. Sarandol, S. Eker, 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?

E. Sarandol, S. Eker, S. Kırlı, 2014, Acta Neuropsychiatrica.

Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases

A. Sarandol, S. Kırlı, C. Ersoy, 2009, Journal of psychopharmacology.

A patient using ziprasidone with polydipsia, seizure, hyponatremia and rhabdomyolysis

A. Sarandol, S. Kırlı, C. Akkaya, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Increased plasma agmatine levels in patients with schizophrenia.

A. Sarandol, S. Eker, S. Kırlı, 2013, Journal of psychiatric research.

Oxidative–antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment

A. Sarandol, E. Sarandol, S. Kırlı, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Metabolic, endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study

E. Sarandol, S. Kırlı, G. Ozkaya, 2011, Therapeutic advances in psychopharmacology.

Trends in the annual incidence rates of narcotics felons arrested over the last 30 years in metropolitan Bursa, Turkey.

S. Kırlı, C. Akkaya, S. Akgoz, 2007, The Tohoku journal of experimental medicine.

A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: A randomized, open-labeled clinical trial

A. Sarandol, S. Eker, S. Kırlı, 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Urticaria and angio-oedema due to ziprasidone

A. Sarandol, S. Kırlı, C. Akkaya, 2007, Journal of psychopharmacology.

Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition

A. Sarandol, S. Eker, S. Kırlı, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[The relationship between the duration of drug use and the bipolar disorder patients' sociodemographic and clinical characteristics].

S. Kırlı, C. Akkaya, Ş. Cangür, 2014, Turk psikiyatri dergisi = Turkish journal of psychiatry.

BİPOLAR BOZUKLUKTA DÖNEM SÜRELERİ ÜZERİNE SOSYODEMOGRAFİK VE KLİNİK ÖZELLİKLERİN ETKİSİ THE EFFECTS OF SOCIODEMOGRAPHIC AND CLINICAL FEATURES ON DURATIONS OF BIPOLAR DISORDER'S PERIODS

S. Kırlı, C. Akkaya, Cem Gündüz, 2012 .

The Burden of Urinary Incontinence on Caregivers and Evaluation of Its Impact on Their Emotional Status

S. Kırlı, Elif Altınay Kırlı, Ş. Türk, 2021, ALPHA PSYCHIATRY.

An investigation of the eating attitudes and coping ways with stress among medical students

S. Kırlı, Esra Doğruel, 2020 .

[Reliability and validity of the Turkish version of the Social Adaptation Self-Evaluation Scale (SASS)].

S. Kırlı, C. Akkaya, E. Y. Sivrioglu, 2008, Turk psikiyatri dergisi = Turkish journal of psychiatry.

Reliability and validity of the Geriatric Depression Scale in detection of poststroke minor depression

S. Kırlı, E. Cankurtaran, B. Ince, 2009, Journal of clinical and experimental neuropsychology.

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study

E. Sarandol, S. Kırlı, G. Ozkaya, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Psychopathology , Psychosocial Factors and Quality of Life in Patients with Myasthenia Gravis

S. Kırlı, G. Özkaya, Z. Kotan, 2016 .

Onset of multiple sclerosis following post‐partum depressive and manic episodes

S. Kırlı, O. Taskapilioglu, O. Turan, 2007, Psychiatry and clinical neurosciences.

Art Therapy with Psoriatic Patients

S. Kırlı, E. Başkan, A. Sarandöl, 2019 .

The efficacy of flupenthixol decanoate in bipolar disorder patients who have no sufficient remission with existing treatments

S. Eker, S. Kırlı, C. Akkaya, 2015 .

Pathological yawning in a patient with anxiety and chronic disease anaemia

A. Sarandol, S. Kırlı, O. Taskapilioglu, 2009, Journal of psychopharmacology.

A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia

S. Kırlı, M. Çalışkan, 1998, Schizophrenia Research.

Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

A. Sarandol, S. Eker, S. Kırlı, 2010 .

The Effectiveness of Risperidone Long-acting Injection in Oral Antipsychotic Non-Adherent Patients with Schizophrenia: A Retrospective Study

A. Sarandol, S. Kırlı, C. Akkaya, 2009 .

The relationship between psychopathology, psychosocial adjustment, social support and quality of life in multiple sclerosis

A. Sarandol, S. Kırlı, G. Ozkaya, 2018 .

Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

A. Sarandol, S. Eker, S. Kırlı, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Reliability and Validity of the Turkish Version of the Social Adapta on Self-Evalua on Scale (SASS)

S. Kırlı, E. Yusuf, C. Akkaya, 2008 .

Retrospective database analysis on the effectiveness of typical and atypical antipsychotic drugs in an outpatient clinic setting

A. Sarandol, S. Kırlı, S. Cangur, 2007, Human psychopharmacology.

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study

E. Sarandol, S. Kırlı, G. Ozkaya, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

A. Sarandol, S. Eker, S. Kırlı, 2010 .

[Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder].

A. Sarandol, S. Kırlı, S. Akgöz, 2005, Turk psikiyatri dergisi = Turkish journal of psychiatry.

Are there differences between serotonergic, noradrenergic and dual acting antidepressants in the treatment of depressed women?

A. Sarandol, S. Eker, S. Kırlı, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases

A. Sarandol, S. Kırlı, C. Akkaya, 2009, Journal of psychopharmacology.

The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study

E. Sarandol, S. Kırlı, E. Sarandöl, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.